Losasio® is a prescription injectable medication containing semaglutide in dosages of 0.5 mg, 1 mg, or 2 mg.Its purpose is to lower the risk of significant cardiovascular events, such as death, heart attack, or stroke, in adults who have known heart disease and are either obese or overweight. Additionally, it may assist adults and children aged 12 years and older who are dealing with obesity, or certain adults with overweight who have weight-related health issues, in achieving and maintaining weight loss.

Losasio® contains semaglutide and should not be combined with other products containing semaglutide or other GLP-1 receptor agonists.

The safety and efficacy of Losasio® in children under the age of 12 have not been established.

Important Safety Information:

What critical information should I be aware of regarding Losasio®?

Losasio® may lead to serious side effects, including:

• The potential for thyroid tumors, including cancer. It is essential to inform your healthcare provider if you experience a lump or swelling in your neck, hoarseness, difficulty swallowing, or shortness of breath, as these may indicate thyroid cancer. Research conducted on rodents has shown that Losasio® and similar medications can induce thyroid tumors, including thyroid cancer.
• However, it remains uncertain whether Losasio® can cause thyroid tumors or a specific type of thyroid cancer known as medullary thyroid carcinoma (MTC) in humans.
• Losasio® should not be used if you or any family member has a history of medullary thyroid carcinoma (MTC) or if you have a condition known as Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
• Additionally, do not use Losasio® if you have experienced a severe allergic reaction to semaglutide or any of its components.
• Prior to using Losasio®, it is advisable to inform your healthcare provider of any other medical conditions you may have.
• The safety and efficacy of Losasio® in individuals with a history of pancreatitis remain undetermined.
• Losasio® is contraindicated for individuals with type 1 diabetes.

Individuals who are pregnant or intend to become pregnant should be aware that the effects of Losasio® on an unborn child are not fully understood.

• It is advisable to discontinue the use of Losasio® at least two months prior to attempting conception. Consultation with your healthcare provider is essential to determine the most effective methods for managing blood sugar levels during the preconception period and throughout pregnancy.
• Additionally, for those who are breastfeeding or considering breastfeeding, it is important to note that the use of Losasio® is not recommended during this time.

Tell your healthcare provider about all the medicines you take:

• Including prescription and over-the-counter medicines, vitamins, and herbal supplements. Losasio^® may affect the way some medicines work and some medicines may affect the way Losasio^® works.
• If you miss a dose of Losasio^®, skip the missed dose and go back to your regular schedule

It is imperative not to share your Losasio® pen with others, even if the needle has been replaced, as this may lead to serious infections for both parties involved.